PHARMACEUTICAL MARKET IN 2024 & NEW TRENDS IN 2025

Xu Huong Duoc Pham 2024 2025

Pharmaceutical Market Size and Growth Rate in 2024

In 2024, the global pharmaceutical market continues to experience strong growth. According to The Business Research Company, the market size will increase from $1,199.86 billion in 2023 to $1,267.05 billion in 2024, with a compound annual growth rate (CAGR) of 5.6%. Population growth and an aging demographic are driving the demand for pharmaceuticals. The rise of chronic and emerging infectious diseases has increased healthcare needs. Growing health awareness and economic development in emerging markets also support the industry.

In the long term, the pharmaceutical and healthcare markets are projected to have high growth potential and significant development opportunities. Vietnam is among the countries with the fastest-growing pharmaceutical industry globally, with an expected CAGR of 6–8% from 2023 to 2028 (according to IQVIA).

Xu Huong Duoc Pham 2024 2025

Industry Trends in 2025

In 2025, the pharmaceutical industry will focus on four key trends: artificial intelligence (AI), personalized medicine, biopharmaceuticals, and sustainable development. AI optimizes drug research and production, reducing costs and time. A report from McKinsey & Company highlights that integrating AI and big data analytics could revolutionize research and development (R&D), cutting costs by 20%–40% and accelerating product launches by up to five times. AstraZeneca also reported that AI has shortened their drug discovery timeline.

Personalized Medicine and Biopharmaceuticals

Personalized medicine aims for more precise treatments based on each patient’s genetic makeup and lifestyle. Genetic analysis technology, molecular biology, and AI play key roles.

By 2025, the personalized medicine market is expected to reach approximately $112 billion, with a CAGR of 11.23% from 2020 to 2025 (Market Research Future).

Biopharmaceuticals play a vital role in treating complex diseases. Significant progress has been made in treating cancer, autoimmune diseases, and genetic disorders. According to EvaluatePharma, biopharmaceutical revenues are estimated to reach about $375 billion by 2025. Leading products like Keytruda (Merck) and Opdivo (Bristol-Myers Squibb) report high sales due to superior efficacy. CAR-T cell therapy, CRISPR-Cas9 technology, and mRNA vaccines offer promising solutions for critical illnesses.

Sustainability and Environmental Friendliness

The pharmaceutical industry is also moving towards sustainable development. Companies are increasingly focusing on eco-friendly practices. For instance, Johnson & Johnson has committed to reducing hazardous chemicals in drug manufacturing. Green production, carbon emission reduction, and optimized logistics are becoming more common.

The future of the pharmaceutical industry will center on smart healthcare services. Online medical platforms, smart wearable devices, and big data will help users monitor their health more easily. The pharmaceutical industry promises to continue advancing, improving public health, and enhancing quality of life.